ALLIANCEBERNSTEIN L.P. - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 180 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 3.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$431,451
-13.1%
99,873
+32.6%
0.00%
Q2 2023$496,510
+15.0%
75,343
+18.5%
0.00%
Q1 2023$431,864
-18.8%
63,603
-11.6%
0.00%
Q4 2022$531,747
-25.1%
71,955
+0.1%
0.00%
Q3 2022$710,000
-9.3%
71,901
+0.1%
0.00%
Q2 2022$783,000
-59.7%
71,817
-58.2%
0.00%
-100.0%
Q1 2022$1,941,000
+73.5%
171,627
+140.6%
0.00%
Q4 2021$1,119,000
-46.1%
71,347
-41.1%
0.00%
-100.0%
Q3 2021$2,077,000
+31.0%
121,203
+64.4%
0.00%0.0%
Q2 2021$1,586,000
+43.3%
73,7230.0%0.00%
Q1 2021$1,107,000
+14.5%
73,723
+0.2%
0.00%
Q4 2020$967,000
+36.0%
73,5830.0%0.00%
Q3 2020$711,000
-15.4%
73,583
+0.3%
0.00%
Q2 2020$840,000
+7.6%
73,393
-2.7%
0.00%
-100.0%
Q1 2020$781,000
-36.8%
75,403
+0.1%
0.00%0.0%
Q4 2019$1,236,000
+24.2%
75,303
+0.5%
0.00%0.0%
Q3 2019$995,000
-18.7%
74,953
-13.8%
0.00%0.0%
Q2 2019$1,224,000
-56.4%
86,903
-43.1%
0.00%
-50.0%
Q1 2019$2,810,000
-29.6%
152,7130.0%0.00%
-33.3%
Q4 2018$3,990,000
+8.2%
152,713
-5.0%
0.00%
+50.0%
Q3 2018$3,689,000
+20.5%
160,7530.0%0.00%0.0%
Q2 2018$3,062,000
+65.5%
160,753
+46.5%
0.00%
+100.0%
Q1 2018$1,850,000
+10.9%
109,7630.0%0.00%0.0%
Q4 2017$1,668,000
-18.5%
109,763
-4.0%
0.00%
-50.0%
Q3 2017$2,047,000
+86.6%
114,363
+69.9%
0.00%
+100.0%
Q2 2017$1,097,000
+62.5%
67,303
+39.6%
0.00%0.0%
Q1 2017$675,000
-83.0%
48,228
-80.6%
0.00%
-66.7%
Q4 2016$3,972,000
-11.8%
249,028
-8.0%
0.00%
-25.0%
Q3 2016$4,504,000
+219.2%
270,678
+114.7%
0.00%
+300.0%
Q2 2016$1,411,000
+245.8%
126,078
+158.2%
0.00%
Q1 2016$408,000
-21.1%
48,828
-12.1%
0.00%
Q4 2015$517,000
-17.4%
55,5280.0%0.00%
-100.0%
Q3 2015$626,000
-11.2%
55,5280.0%0.00%0.0%
Q2 2015$705,000
+36.6%
55,5280.0%0.00%
Q1 2015$516,000
-35.1%
55,5280.0%0.00%
-100.0%
Q4 2014$795,000
+38.0%
55,5280.0%0.00%
Q3 2014$576,000
-35.9%
55,5280.0%0.00%
-100.0%
Q2 2014$898,000
-21.4%
55,528
-21.1%
0.00%0.0%
Q1 2014$1,143,000
+113.2%
70,341
+62.7%
0.00%
Q4 2013$536,000
+13.1%
43,2280.0%0.00%
Q3 2013$474,000
-33.9%
43,228
-51.3%
0.00%
-100.0%
Q2 2013$717,00088,7490.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 2,491,200$27,154,0002.37%
Profit Investment Management, LLC 281,890$3,071,0002.26%
Sio Capital Management, LLC 488,965$5,330,0002.00%
Zebra Capital Management LLC 14,766$161,0000.47%
Prairiewood Capital, LLC 50,165$547,0000.43%
TANG CAPITAL MANAGEMENT LLC 256,696$2,798,0000.42%
HUSSMAN STRATEGIC ADVISORS, INC. 156,000$1,700,0000.29%
GLOBEFLEX CAPITAL L P 100,843$1,099,0000.27%
Epoch Investment Partners, Inc. 2,757,646$30,059,0000.18%
EMC Capital Management 16,185$176,0000.15%
View complete list of VANDA PHARMACEUTICALS INC shareholders